Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid

被引:5
|
作者
Meshanni, Jaclynn A. [1 ]
Lee, Jordan M. [1 ]
Vayas, Kinal N. [1 ]
Sun, Rachel [1 ]
Jiang, Chenghui [1 ]
Guo, Grace L. [1 ]
Gow, Andrew J. [1 ]
Laskin, Jeffrey D. [2 ]
Laskin, Debra L. [1 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth & Justice, Piscataway, NJ 08854 USA
基金
美国国家卫生研究院;
关键词
PULMONARY INJURY; BILE-ACIDS; MACROPHAGE ACTIVATION; LIPID HOMEOSTASIS; REACTIVE OXYGEN; KAPPA-B; ATTENUATION; MICE; DISRUPTION; MECHANISMS;
D O I
10.1124/jpet.123.001557
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nitrogen mustard (NM) is a cytotoxic vesicant known to cause pulmonary injury that can progress to fibrosis. NM toxicity is associated with an influx of inflammatory macrophages in the lung. Farnesoid X receptor (FXR) is a nuclear receptor involved in bile acid and lipid homeostasis that has anti-inflammatory activity. In these studies, we analyzed the effects of FXR activation on lung injury, oxidative stress, and fibrosis induced by NM. Male Wistar rats were exposed to phosphate-buffered saline (vehicle control) or NM (0.125 mg/kg) by intratracheal Penncentury-MicroSprayer aerosolization; this was followed by treatment with the FXR synthetic agonist, obeticholic acid (OCA, 15 mg/kg), or vehicle control (0.13-0.18 g peanut butter) 2 hours later and then once per day, 5 days per week thereafter for 28 days. NM caused histopathological changes in the lung, including epithelial thickening, alveolar circularization, and pulmonary edema. Picrosirius red staining and lung hydroxyproline content were increased, indicative of fibrosis; foamy lipid-laden macrophages were also identified in the lung. This was associated with aberrations in pulmonary function, including increases in resistance and hysteresis. Following NM exposure, lung expression of HO-1 and iNOS, and the ratio of nitrates/nitrites in bronchoalveolar lavage fluid (BAL), markers of oxidative stress increased, along with BAL levels of inflammatory proteins, fibrinogen, and sRAGE. Administration of OCA attenuated NM-induced histopathology, oxidative stress, inflammation, and altered lung function. These findings demonstrate that FXR plays a role in limiting NM-induced lung injury and chronic disease, suggesting that activating FXR may represent an effective approach to limiting NM-induced toxicity.
引用
收藏
页码:586 / 595
页数:10
相关论文
共 50 条
  • [41] Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal Maturation
    Weber, Andre A.
    Mennillo, Elvira
    Yang, Xiaojing
    van der Schoor, Lori W. E.
    Jonker, Johan W.
    Chen, Shujuan
    Tukey, Robert H.
    DRUG METABOLISM AND DISPOSITION, 2021, 49 (01) : 12 - 19
  • [42] An improved synthesis of 6α-ethylchenodeoxycholic acid (6ECDCA), a potent and selective agonist for the Farnesoid X Receptor (FXR)
    Yu, Donna
    Mattern, Daniell L.
    Forman, Barry M.
    STEROIDS, 2012, 77 (13) : 1335 - 1338
  • [43] Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
    Zhang, Songwen
    Wang, Juan
    Liu, Qiangyuan
    Harnish, Douglas C.
    JOURNAL OF HEPATOLOGY, 2009, 51 (02) : 380 - 388
  • [44] The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury
    Ferrigno, Andrea
    Di Pasqua, Laura Giuseppina
    Berardo, Clarissa
    Siciliano, Veronica
    Rizzo, Vittoria
    Adorini, Luciano
    Richelmi, Plinio
    Vairetti, Mariapia
    PLOS ONE, 2018, 13 (01):
  • [45] LONG-TERM (LT) THERAPY OF A FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) MAINTAINS BIOCHEMICAL RESPONSE IN PRIMARY BILIARY CIRRHOSIS (PBC)
    Hirschfield, G.
    Kowdley, K.
    Mason, A.
    Luketic, V.
    Gordon, S.
    Vincent, C.
    Mayo, M.
    Pares, A.
    Chapman, R.
    Lindor, K.
    Esguerra, M.
    Eliot, L.
    Shapiro, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S372 - S372
  • [46] THE FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) INCREASES PLASMA FGF-19 CONCENTRATIONS AND DECREASES BILE ACID SYNTHESIS IN PRIMARY BILIARY CIRRHOSIS (PBC)
    Marschall, H. -U.
    Luketic, V.
    Lovgren-Sandblom, A.
    Benthin, L.
    Kowdley, K.
    Hirschfield, G.
    Mason, A.
    Lindor, K.
    Gordon, S.
    Vincent, C.
    Chapman, R.
    Mayo, M.
    Burroughs, A.
    Pares, A.
    Jones, D.
    Schramm, C.
    Eliot, L.
    Hofmann, A. F.
    Shapiro, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S377 - S377
  • [47] Chronic Exposure to Electronic Cigarettes Induces Lung Oxidative Stress, Inflammation, Fibrosis, and Impaired DNA Repair
    Eid, Mahmoud S.
    Ewees, Mohamed G.
    El-Mahdy, Mohamed A.
    Zweier, Jay L.
    FASEB JOURNAL, 2022, 36
  • [48] Evaluation of the Effects of Meal Type and Acid-Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist
    Weber, Elijah J.
    Younis, Islam R.
    Wang, Lulu
    Xiao, Deqing
    Barchuk, William T.
    Othman, Ahmed A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (06): : 677 - 687
  • [49] Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases
    Festa, Carmen
    De Marino, Simona
    Carino, Adriana
    Sepe, Valentina
    Marchiano, Silvia
    Cipriani, Sabrina
    Di Leva, Francesco S.
    Limongelli, Vittorio
    Monti, Maria C.
    Capolupo, Angela
    Distrutti, Eleonora
    Fiorucci, Stefano
    Zampella, Angela
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [50] THE FARNESOID X RECEPTOR AGONIST, OBETICHOLIC ACID, IMPROVES INTESTINAL ANTIBACTERIAL DEFENSE AND REDUCES GUT BACTERIAL TRANSLOCATION AND HEPATIC FIBROGENESIS IN CCl4-CIRRHOTIC RATS WITH ASCITES
    Ubeda, M.
    Borrero, M. J.
    Lario, M.
    Munoz, L.
    Conde, E.
    Rodriguez, M.
    LLedo, L.
    Garcia-Bermejo, L.
    Alvarez-Mon, M.
    Albillos, A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S63 - S63